<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-IND-T-FIND-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening sustainable Laboratory Diagnostic Network of RNTCP and Joint Effort for Elimination of Tuberculosis (JEET) - India (01-Jan-2018-31-Mar-2021)</narrative>
    </title>
    <description type="1">
      <narrative>India, Tuberculosis, Foundation for Innovative New Diagnostics India</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To achieve a rapid decining burden of TB morbidity and mortality while working towards elimination of TB in India by 2025. Objectives: Systematically engage the private provides  with an increase in case notification to 2 million cases annually; Improving treatment adherence and treatment support byadoption of iCT tools and partnerships; Strengthen linkages with the Pharmacovigilance program of india ( PvPI) for monitoring, identification and detection of signals; Health system strengthening with focus on mechanisms for critical mangement reforms, restructuring HR and Financial norms.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Foundation for Innovative New Diagnostics India</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Foundation for Innovative New Diagnostics India</narrative>
    </participating-org>
    <other-identifier ref="IND-T-FINDP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2021-03-31" />
    <activity-date type="4" iso-date="2021-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Gyongyver Jakab</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>gyongyver.jakab@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="IN" percentage="100">
      <narrative>India</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="82.43">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="17.57">
      <narrative>Multicomponent</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="17.57">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="68.04">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="14.39">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">4615440.63</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">7398787.99</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">19947486.86</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">16842006.02</value>
    </budget>
    <capital-spend percentage="39.68" />
    <transaction ref="8ff6b1db-2562-4fc0-b129-28cf6940ea9c">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-02-15" />
      <value currency="USD" value-date="2018-02-15">16274982.26</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3554e7d8-d00c-4550-9ab6-098b9fe60a6b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-02-16" />
      <value currency="USD" value-date="2018-02-16">1042518.32</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="42e40933-b186-42fa-84b1-f425e4e336f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-07-31" />
      <value currency="USD" value-date="2018-07-31">4712470.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ae8dd1da-516f-4696-a1bc-b9e2fde6ab6f">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-07" />
      <value currency="USD" value-date="2019-02-07">4860294.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25b48941-9a68-4625-9dee-50fcc78964e4">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-09-19" />
      <value currency="USD" value-date="2019-09-19">-5659699.94</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f7e5063f-d1aa-4891-a7f5-890623f1a2c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-09-19" />
      <value currency="USD" value-date="2019-09-19">13779980.24</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d93cff98-a615-4835-9bc8-6a034e7925ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-20" />
      <value currency="USD" value-date="2019-09-20">1825792.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fdec4355-a8db-4c4f-b6b6-a34a6be0a916">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-12" />
      <value currency="USD" value-date="2019-12-12">4704353.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ad1dce4-8c36-46de-b2c3-a44babff954e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-03" />
      <value currency="USD" value-date="2020-04-03">1717549.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="44cba445-a232-4597-a031-39fcf17b83d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-09-02" />
      <value currency="USD" value-date="2020-09-02">-5532286.24</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7fcd185a-dca2-4ff1-9187-14a7383cc099">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-09-02" />
      <value currency="USD" value-date="2020-09-02">8020361.62</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c7865342-957e-4582-98de-9a476f695631">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-09" />
      <value currency="USD" value-date="2020-09-09">1107241.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="60a3067d-e775-4655-a34a-bae0caafccbf">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-19" />
      <value currency="USD" value-date="2020-11-19">-6913120.62</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="90aebd79-9f8f-4073-b6ab-499c596c8bf6">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-19" />
      <value currency="USD" value-date="2020-11-19">28833504.68</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="73b2cb29-c27e-4d08-bcd8-5e129993ed08">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-25" />
      <value currency="USD" value-date="2020-11-25">3172214.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06088806-ea7f-40f7-9deb-4bd8606369bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-23" />
      <value currency="USD" value-date="2021-04-23">11310807.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1d127782-2fd7-4d62-9bf0-98913ff28698">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-15" />
      <value currency="USD" value-date="2021-09-15">-14350483.68</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bbe31529-f1ec-4ab4-8542-9ae8c2089eca">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-15" />
      <value currency="USD" value-date="2021-09-15">0.00</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72d3c98b-a9d5-43dd-bf7a-7bfc4e2e6bd2">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-25" />
      <value currency="USD" value-date="2022-05-25">22514.49</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c9f3f5d5-afbc-43b5-b0c7-e9533b6ab187">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-02" />
      <value currency="USD" value-date="2022-06-02">22514.49</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP01 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="IND-T-FINDP01-EXP-20190331">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-03-31" />
      <value currency="USD" value-date="2019-03-31">6098749.66</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP01, Jan 2018 to Mar 2019.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP01-EXP-20200331">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-03-31" />
      <value currency="USD" value-date="2020-03-31">7710752.09</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP01, Apr 2019 to Mar 2020.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP01-EXP-20210331">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-03-31" />
      <value currency="USD" value-date="2021-03-31">7202254.67</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP01, Apr 2020 to Mar 2021.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP01-EXP-20210930">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">6972485.71</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP01, Apr 2021 to Sep 2021.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/IND-T-FIND" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-IND-T-FIND-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthening health systems for sustainable access to quality diagnosis, engagement of private sector, management of latent TB and amplifying community action for achieving TB elimination in India - India (01-Apr-2021-31-Mar-2024)</narrative>
    </title>
    <description type="1">
      <narrative>India, Tuberculosis, Foundation for Innovative New Diagnostics India</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To achieve a rapid decline in burden of TB, morbidity and mortality to achieve the Sustainable Development Goals of 80% reduction in incidence and 90% reduction in deaths by 2025; five years earlier than the stipulated timeline. Objectives: Build, strengthen and sustain enabling policies, empowered institutions, multi-sectoral collaborations, engaged communities, and human resources with enhanced capacities to create a supportive ecosystem to END TB; Prevent the emergence of TB in susceptible populations; To train  and engage selected TB Champions to improve community awareness and preparedness for TB and COVID-19 through advanced communications skilling; To facilitate the formation and strengthening of local rapid response teams, led by TB Champions in coordination with local health officers and CHOs, to ensure that people with TB/COVID receive timely and appropriate services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>Foundation for Innovative New Diagnostics India</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>Foundation for Innovative New Diagnostics India</narrative>
    </participating-org>
    <other-identifier ref="IND-T-FINDP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-04-01" />
    <activity-date type="2" iso-date="2021-04-01" />
    <activity-date type="3" iso-date="2024-03-31" />
    <activity-date type="4" iso-date="2024-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Gyongyver Jakab</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>gyongyver.jakab@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="IN" percentage="100">
      <narrative>India</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="77.3">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="22.7">
      <narrative>Multicomponent</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="22.7">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="50.04">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="12.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="1.67">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="13.37">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">10722546.04</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">17361689.99</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">22244514.76</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">10500815.39</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1647795.83</value>
    </budget>
    <capital-spend percentage="22.45" />
    <transaction ref="16326dc2-91ed-49d1-864c-9b87ef2453fe">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-05-03" />
      <value currency="USD" value-date="2021-05-03">18549407.04</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6f0f10b5-2885-4d46-9989-a0233fec0d44">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-07" />
      <value currency="USD" value-date="2021-05-07">1931742.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21ccd8f0-4050-4b4f-bab3-08767cd841d5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-12" />
      <value currency="USD" value-date="2021-08-12">3124551.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b8ab67ff-c06f-4a1b-88e0-4c73dbfb8d34">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">7338606.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d052c0a-2371-4fe5-a18a-707e2e950155">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-18" />
      <value currency="USD" value-date="2021-11-18">230845.58</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="175b58ac-6930-4274-bc50-411b8a52670b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-18" />
      <value currency="USD" value-date="2021-12-18">18089965.97</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f3dd9e61-467b-418c-98c6-d02acda391c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-18" />
      <value currency="USD" value-date="2021-12-18">-5923662.46</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2aa79f4b-a87a-4a1c-b55c-4f92a22a5e39">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">10380750.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b31d2688-1227-49e9-83c3-0eaff4874d88">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-11" />
      <value currency="USD" value-date="2022-08-11">1968656.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7dfbffae-ffd0-4005-a318-08b0f6d95693">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-18" />
      <value currency="USD" value-date="2022-08-18">6935.76</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bfa95c2a-1069-4d5c-8de6-0f98d8e4f7f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-06" />
      <value currency="USD" value-date="2022-10-06">12075.63</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ea365d38-947c-43d5-bc91-cf04cabc3951">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-06" />
      <value currency="USD" value-date="2022-10-06">3609.73</value>
      <description>
        <narrative>Funds returned to the Global Fund from IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25b5255c-6812-474a-8e61-e62c8c9f26ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-07" />
      <value currency="USD" value-date="2022-10-07">-3609.73</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5e0b123-cf61-48b9-9961-84db857f93a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-06" />
      <value currency="USD" value-date="2022-12-06">1721885.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15ca309f-5d8a-462c-9281-c7f505028877">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-16" />
      <value currency="USD" value-date="2022-12-16">15637911.89</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2cc05474-8b44-40bf-b8d1-f48d2592c990">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-16" />
      <value currency="USD" value-date="2022-12-16">-3999663.58</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="181c0391-22be-4db1-887b-135c5aaa4824">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">3537690.98</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eab70410-bc6c-4833-85ab-3d98473aaf29">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">2806488.89</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a556baec-8257-46d4-bf30-f56c44d4e0b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">19223.84</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="be37ff7f-ba72-4aa6-8d28-cc80a5dbd300">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-06-01" />
      <value currency="USD" value-date="2023-06-01">2213.12</value>
      <description>
        <narrative>Funds returned to the Global Fund from IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="49fc75ba-ce86-48c4-b7ca-acc264ae40b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">2390115.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e8cde183-4e3a-406e-9ce2-0a73c12a4ac5">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">4332266.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7db4c30b-74be-46ec-ba92-de804e214d78">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">-2213.12</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7afff06-a248-4cf2-a154-c54a431d06a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">-2552127.18</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef11d9f9-e421-49d4-a8a9-840ac815e6d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">14557885.00</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="526047a9-b0d6-4677-84e5-30c2bf6b94b8">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">1741601.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="874a2af4-c691-47a8-8c0e-5b28b19292dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-27" />
      <value currency="USD" value-date="2024-03-27">3809572.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9bcd3d47-4151-43d3-af5e-3e6173352564">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">143.51</value>
      <description>
        <narrative>Funds returned to the Global Fund from IND-T-FINDP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5f6b8c9b-d4b4-491e-9f52-dfc1245585ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-04" />
      <value currency="USD" value-date="2024-07-04">-143.51</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c52301ac-d841-4ee3-a35f-e5dd20050142">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-29" />
      <value currency="USD" value-date="2024-08-29">527132.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d73824d2-1941-4f17-af0f-a085e34ffeea">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-12" />
      <value currency="USD" value-date="2024-12-12">-8479580.00</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e39691a1-fd4e-47c3-b341-4551d55155c7">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-12" />
      <value currency="USD" value-date="2024-12-12">45661.00</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4121dc70-335c-4831-b6d6-41641dbc3266">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-18" />
      <value currency="USD" value-date="2024-12-18">45661.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1d53b52d-c898-4df6-99c9-ce6fea65217e">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-01-21" />
      <value currency="USD" value-date="2025-01-21">4520990.00</value>
      <description>
        <narrative>Global Fund commitment to IND-T-FINDP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83296d91-f03c-4bb8-82c7-efa596f58946">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-23" />
      <value currency="USD" value-date="2025-01-23">763505.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="77881244-5f6f-497d-b053-c2ec14df65f7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">2113797.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="184bcb8b-2cb5-4628-982c-23116bfbe041">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-05" />
      <value currency="USD" value-date="2026-05-05">23100.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7b883383-ca81-428c-a737-2716859e3e0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-03" />
      <value currency="USD" value-date="2026-06-03">180996.00</value>
      <description>
        <narrative>Global Fund disbursement to IND-T-FINDP02 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="IND-T-FINDP02-EXP-20220331">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-03-31" />
      <value currency="USD" value-date="2022-03-31">16958074.89</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP02, Apr 2021 to Mar 2022.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP02-EXP-20230331">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-03-31" />
      <value currency="USD" value-date="2023-03-31">10026861.63</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP02, Apr 2022 to Mar 2023.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP02-EXP-20240331">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-03-31" />
      <value currency="USD" value-date="2024-03-31">13541564.91</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP02, Apr 2023 to Mar 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP02-EXP-20240930">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">1378359.46</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP02, Apr 2024 to Sep 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP02-EXP-20250331">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-03-31" />
      <value currency="USD" value-date="2025-03-31">661452.00</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP02, Oct 2024 to Mar 2025.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <transaction ref="IND-T-FINDP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">2804791.35</value>
      <description>
        <narrative>Expenditure reported by Foundation for Innovative New Diagnostics India for IND-T-FINDP02, Apr 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="21">
        <narrative>Foundation for Innovative New Diagnostics India</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/IND-T-FIND" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/IND/2020/Tuberculosis/en/IND-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Tuberculosis - India - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR866-IND-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR TB-Other 1: Percentage of CBNAAT laboratories (GeneXpert) showing adequate performance on External Quality Assurance</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>MDR TB-Other 1: Percentage of CBNAAT laboratories (GeneXpert) showing adequate performance on External Quality Assurance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="98.04">
          <comment>
            <narrative>Numerator: 651; Denominator: 664.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1287; Denominator: 1355.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 1260; Denominator: 1288.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="94.98">
            <comment>
              <narrative>Numerator: 1287; Denominator: 1355.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 1260; Denominator: 1288.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1358; Denominator: 1430.</narrative>
            </comment>
          </target>
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 1424; Denominator: 1454.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="94.97">
            <comment>
              <narrative>Numerator: 1358; Denominator: 1430.</narrative>
            </comment>
          </target>
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 1424; Denominator: 1454.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1430; Denominator: 1505.</narrative>
            </comment>
          </target>
          <actual value="98.1">
            <comment>
              <narrative>Numerator: 1583; Denominator: 1613.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 1430; Denominator: 1505.</narrative>
            </comment>
          </target>
          <actual value="98.1">
            <comment>
              <narrative>Numerator: 1583; Denominator: 1613.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="44.44">
          <comment>
            <narrative>Numerator: 36; Denominator: 81.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="51.85">
            <comment>
              <narrative>Numerator: 42; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="51.9">
            <comment>
              <narrative>Numerator: 42; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="58">
            <comment>
              <narrative>Numerator: 47; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="55.6">
            <comment>
              <narrative>Numerator: 45; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="58.03">
            <comment>
              <narrative>Numerator: 47; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="55.6">
            <comment>
              <narrative>Numerator: 45; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="65.43">
            <comment>
              <narrative>Numerator: 53; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="61.7">
            <comment>
              <narrative>Numerator: 50; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="76.5">
            <comment>
              <narrative>Numerator: 62; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="59.3">
            <comment>
              <narrative>Numerator: 48; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="76.54">
            <comment>
              <narrative>Numerator: 62; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="59.3">
            <comment>
              <narrative>Numerator: 48; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="95.1">
            <comment>
              <narrative>Numerator: 77; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="71">
            <comment>
              <narrative>Numerator: 49; Denominator: 69.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="88.89">
            <comment>
              <narrative>Numerator: 72; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="73.5">
            <comment>
              <narrative>Numerator: 50; Denominator: 68.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="95.06">
            <comment>
              <narrative>Numerator: 77; Denominator: 81.</narrative>
            </comment>
          </target>
          <actual value="71">
            <comment>
              <narrative>Numerator: 49; Denominator: 69.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="20965" />
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="26670" />
          <actual value="17493" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="35560" />
          <actual value="25210" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="8890" />
          <actual value="7717" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCP-Other 4: Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated from private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCP-Other 4: Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated from private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="81.22">
          <comment>
            <narrative>Numerator: 257768; Denominator: 317361.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 42240; Denominator: 48000.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 38220; Denominator: 43529.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 42240; Denominator: 48000.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 38220; Denominator: 43529.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="89">
            <comment>
              <narrative>Numerator: 79459; Denominator: 89280.</narrative>
            </comment>
          </target>
          <actual value="88.6">
            <comment>
              <narrative>Numerator: 80561; Denominator: 90915.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 43575; Denominator: 48960.</narrative>
            </comment>
          </target>
          <actual value="88.6">
            <comment>
              <narrative>Numerator: 42337; Denominator: 47777.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="89">
            <comment>
              <narrative>Numerator: 35884; Denominator: 40320.</narrative>
            </comment>
          </target>
          <actual value="88.6">
            <comment>
              <narrative>Numerator: 38224; Denominator: 43138.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="71.6">
          <comment>
            <narrative>Numerator: 10214; Denominator: 14266.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 19050; Denominator: 25400.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 19839; Denominator: 23297.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 10583; Denominator: 14111.</narrative>
            </comment>
          </target>
          <actual value="85">
            <comment>
              <narrative>Numerator: 12214; Denominator: 14370.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 8467; Denominator: 11289.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 7625; Denominator: 8927.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>